Evidence map›Paper›PMID 20123080›Full record

ArticleAnalytical biochemistry2010

Antigenic changes in human albumin caused by reactivity with the occupational allergen diphenylmethane diisocyanate.

Adam V Wisnewski, Jian Liu, Carrie A Redlich

Open access · greenAbstract read
In one paragraph

Article in Analytical biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. In vitro cleavage of diisocyanate-glutathione conjugates by human gamma-glutamyl transpeptidase-1.Xenobiotica; the fate of foreign compounds in biological systems · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Adam V WisnewskiDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, USA. adam.wisnewski@yale.edu
Jian Liu
Carrie A Redlich
Yale University · US

Funding

New Serodiagnostics for Isocyanate Exposure, A Major Cause of Occupational AsthmaR42ES016728 · NIEHS · L2 DIAGNOSTICS, LLC · PI WISNEWSKI, ADAM · 2009 to 2010
$710k
Bio-monitoring Methylene Diphenyl Diisocyanate (MDI) exposure and body burdenR41ES018021 · NIEHS · L2 DIAGNOSTICS, LLC · PI WISNEWSKI, ADAM · 2010 to 2010
$211k
NIEHS NIH HHS R41 ES018021NIEHS NIH HHS R41-ES018021NIEHS NIH HHS R42 ES016728NIEHS NIH HHS R42-ES016728
6 · The paper itself

Abstract

Diphenylmethane diisocyanate (MDI), the chemical commonly used as a cross-linking agent in commercial polyurethane production, is a well-recognized cause of asthma. Reaction products between MDI and "self" proteins are hypothesized to act as antigens capable of inducing airway inflammation and asthma; however, such MDI antigens remain incompletely understood. We used a variety of analytical methods to characterize the range of MDI-albumin reaction products that form under physiological conditions. Sites of MDI conjugation on antigenic MDI-albumin products, as defined by serum immunoglobulin G (IgG) from MDI-exposed workers, were determined by high-performance liquid chromatography (HPLC) followed by tandem mass spectrometry (MS/MS). The data identified 14 MDI conjugation sites (12 lysines and 2 asparagines) on human albumin and highlight reaction specificity for the second lysine in dilysine (KK) motifs, and this may be a common characteristic of "immune-sensitizing" chemicals. Several of the MDI conjugation sites are not conserved in albumin from other species, and this may suggest species differences in epitope specificity for self protein (albumin)-isocyanate conjugates. The study also describes new applications of contemporary proteomic methodology for characterizing and standardizing MDI-albumin conjugates destined for use in clinical research.

Indexed as

AllergensAmino Acid SequenceBenzhydryl CompoundsBinding SitesChromatography, High Pressure LiquidEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GIsocyanatesLysineMolecular Sequence DataOccupational ExposurePeptidesSerum AlbuminTandem Mass Spectrometry4,4'-diphenylmethane diisocyanateAllergensBenzhydryl CompoundsImmunoglobulin GIsocyanatesLysinePeptidesSerum Albumin

Identifiers

PMID20123080
PMCPMC3106273
OpenAlexW2010188725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.